The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion.

Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to new research. Apixaban lowers the ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

LISBON — After delaying cardioversion based on a "wait-and-see" (WAS) approach for recent onset, symptomatic atrial fibrillation (AF) was just as good as acute cardioversion (AC) in getting patients ...

Please provide your email address to receive an email when new articles are posted on . Sinus rhythm was restored in an effective, safe and rapid manner using drug-shock or shock-only strategies among ...

A Food and Drug Administration (FDA) advisory committee has voted 11 to 2 against a recommendation that the agency approve a long-studied antiarrhythmic agent for cardioversion of recent-onset atrial ...

Pharmacologic cardioversion followed by electrical cardioversion and electrical cardioversion only were found to be safe and effective in patients presenting to the emergency department with recent ...

VANCOUVER, Feb. 13, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME) (TSX: COM) today announced that a poster titled "Medical conversion with Vernakalant on postoperative cardio-surgical ...

Please provide your email address to receive an email when new articles are posted on . Atrial fibrillation is extraordinarily common, and I see it an insane number of times. I have organized a set ...

MINNEAPOLIS--(BUSINESS WIRE)--Cardialen, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin a clinical trial of its ...